Why the study?
Does levosimendan continuous infusion improve hemodynamics in critically ill patients with cardiogenic shock requiring catecholamines?
Population
10 critically ill patients with cardiogenic shock requiring catecholamines
Design
Case_series
Follow-up
24 hours
Authors
Loading...
May support levosimendan in catecholamine-dependent cardiogenic shock; hypothesis-generating and requires RCTs before practice change.
Does levosimendan continuous infusion improve hemodynamics in critically ill patients with cardiogenic shock requiring catecholamines?
Levosimendan infusion is feasible and improves hemodynamic parameters in critically ill patients with cardiogenic shock requiring catecholamines.
Karth et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: